The project titled "Clinical Risk Prediction in Multiple Myeloma Using an AI-Driven Analysis of the TLR3–NF-κB Signaling Pathway and the Bone Marrow Immune Microenvironment," led by master student Dr. Mihriban YILDIRIM from the ERU Department of Immunology of the Institute of Health Sciences, has been awarded funding by TÜSEB under the A2 Support Program for Master Students. The project team includes Assoc. Prof. Çağman TAN from ERU Faculty of Medicine as an advisor.

Congratulations to our researchers and we wish them continued success.